InnoCan Pharma (TSE:INNO) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Innocan Pharma has announced promising results from a safety assessment of its LPT-CBD injectable on minipigs, showing excellent tolerance and no adverse effects. This study supports the feasibility of LPT-CBD’s safety evaluations, paving the way for future regulatory milestones in chronic pain treatment.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue